The Medlab Asia 2023 was held from August 16th – 18th at IMPACT Exhibition Center, Bangkok. The exhibition, housing 7500 visitors from over 50 countries, serves as one of the most important platforms for companies to bring the latest laboratory products and technologies to South Asia.
As the world’s leading healthcare&diagnostic solutions provider who is dedicated to developing accessible laboratory technologies, products, and services for all, Sansure shared many of its recent breakthroughs at this Medlab Asia 2023.
Main Breakthroughs of Sansure at Medlab Asia 2023
Sansure’s presentation can be divided into three parts, and the product presentation is the most basic. The renowned company also deliver diagnostic solutions, explanation, and expert lecture to help visitors to understand Sansure’s in vitro diagnostic solutions.
1. Product Presentation
At the exhibition showcases the advanced and efficiency-boosting nucleic acid extraction systems, including Natch CS2, Natch 48, and Natch 16S.
Natch CS2 is a fully automated nucleic acid extraction system that is compatible with various original sample tubes and can handle up to 96 tests. Natch 48 and Natch 16S are more compact; the previous can handle up to 48 tests, and the latter 16. They can be applied in different case scenarios, providing more flexible diagnostic solutions for mid to small-sized labs.
Point-of-Care Testing (POCT) device, iPonatic III, also made a salute. The portable molecular workstation accelerates the testing process, allowing results to come out in 15-45 minutes.
2. Solution Presentation: Workshop–Accurate Test for Better Health: The Sansure Strategy
At the Workshop–Accurate Test for Better Health: The Sansure Strategy, Sansure invited two experts to deliver lectures regarding HBV and HIV, and Sansure provided diagnostic solutions, including the diagnostic testing kits and instruments, which have been approved for their accuracy and efficiency.
And in the afternoon, Sansure Medical Affairs Manager, Melvin Pasay, delivered a lecture regarding respiratory tract infection and went through Six Respiratory Pathogens diagnostic solutions, and presented HPV diagnostic demo. They sincerely believe early identification of viral agents is associated with better clinical outcomes, as it results in the timely initiation of therapy.
Commitment and Prospect
In the field of laboratory diagnosis, Sansure is not just one of the fast-emerging names. It is also innovating fast and made significant strides in a decade or so. Sansure continues to develop and deliver more accurate, efficient, and innovative solutions for pathogen identification and disease diagnosis, aiming to guard people’s life. Stay close to see how Sansure digs out the untapped potential of modern medical technologies.
